4D Molecular Therapeutics, Inc. (NASDAQ: FDMT) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT 4D MOLECULAR THERAPEUTICS, INC.

4D Molecular Therapeutics, Inc. (NASDAQ: FDMT)
Listen to this Section


$9.02
+0.1860 ( +2.11% ) 313.4K

4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-125, 4D-110, and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector) 4D-310.

Clinical Trial Pipeline Stages


Drug Name Stage
4D-150DetailsDiabetic macular edema Phase 2
4D-310DetailsFabry disease Phase 1/2
4D-710DetailsCystic fibrosis Phase 1/2
4D-125DetailsX-linked retinitis pigmentosa Phase 1/2
4D-150DetailsWet age-related macular degeneration Phase 1/2
4D-110DetailsChoroideremia Phase 1
4D-175DetailsGeographic atrophy Phase 1

Market Data


Open $9.02
Previous Close $8.84
Volume 313.4K
Market Cap $461.86M
Day Range $8.62 - $9.38
52 Week Range $3.68 - $12.34
Shares Outstanding 52.28M
Change % +2.11%
Net Change ▲ 0.1860
Insider Ownership -0.36%
Exchange NASDAQ
SectorHealthcare
IndustryBiotechnology
IPO Year2020
CountryUnited States
UnderwriterIPO Intelligence Only

Insider Ownership Transactions

Total Amount Purchased: -58,662.00

Date Type Amount Purchased Purchaser
2024-07-18 Sale -500.00 Bizily Scott
2024-07-15 Sale -1996.00 Bizily Scott
2024-07-12 Sale -11653.00 Kirn David
2024-07-03 Sale -1332.00 Bizily Scott
2024-06-26 Sale -12930.00 Kirn David
2024-05-23 Sale -22500.00 GRAY SUSANNAH
2024-05-20 Sale -500.00 Bizily Scott
2024-04-18 Sale -500.00 Bizily Scott
2024-03-29 Sale -4342.00 Bizily Scott
2024-03-20 Sale -500.00 Bizily Scott

SEC Filings


Form Type Description Pages Date
4 Insider transactions 1 Sep 26, 2025
8-k 8K-related 12 Aug 11, 2025
10-q Quarterly Reports 86 Aug 11, 2025
8-k 8K-related 10 Jul 02, 2025
4 Insider transactions 1 Jun 20, 2025
4 Insider transactions 1 Jun 20, 2025
4 Insider transactions 1 Jun 20, 2025
4 Insider transactions 1 Jun 20, 2025
4 Insider transactions 1 Jun 20, 2025
8-k 8K-related 10 Jun 20, 2025

Latest News


× Before browsing our site, please accept our cookies policy